In previous studies, the down-regulation of SESN2 was shown to accelerate both colitis and colon carcinogenesis, while SESN1 and SESN3 were found to be strongly down-regulated in various types of cancer tissues, such as lung cancers and lymphomas.34 This evidence concerns the gene SESN2 and lung carcinoma.